T-cell response to HIV in natural infection: Optimized culture conditions for detecting responses to gag peptides

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 4, 1997, Pages 257-263

  Adams, Susan L ^a   Biti, Robyn A ^a   Stewart, Graeme J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Gag; HIV; Peptides; Proliferation; TH epitopes

Indexed keywords

GAG PROTEIN; INTERLEUKIN 2;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0030813449     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199708010-00002     Document Type: Article

References (20)

1. Schrier RD, Gnann JW, Landes R. T cell recognition of HIV synthetic peptides in a natural infection. J Immunol 1989;142: 1166-76.
2. Wahren B, Rosen J, Sandstrom E, Mathieson T, Modrow S, Wigzell H. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons. J Acquir Immune Defic Syndr 1989; 4:448-56.
3. Clerici M, Stocks NI, Zajac RA. Interleukin 2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989;339: 383-5.
4. Lane HC, Depper JM, Greene WG, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985; 313:79-84.
5. Siliciano RF, Lawton T, Knall C, et al. Analysis of host-virus interactions in AIDS with anti gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 1988;54:561-75.
6. Takahashi H, Germain RN, Moss B, Berzofsky JA. An immunodominant class 1-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. J Exp Med 1990;171:571-6.
7. Palker TJ, Matthews TJ, Langloid A. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol 1989;142:3612-9.
8. Berzofsky JA, Pendleton CD, Clerici M, et al. Construction of peptides encompassing multideterminant clusters of HIV envelope to induce in vitro T-cell responses in mice and humans of multiple MHC types. J Clin Invest 1991;88:876-84.
9. Clerici M, Giorgi J, Chou C-C, et al. Cell mediated immune response to human immunodeficiency virus type 1 (HIV-1) in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-9.
10. Pederson C, Nielsen CM, Vestergaard BF, et al. Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. BMJ 1987;295:567-9.
11. Walker MC, Fast PE, Graham BS, Belshe R, Dolin R. Phase 1/11 preventative vaccine trials: conference summary. AIDS Res Hum Retroviruses 1995;11:1279-85.
12. Berzofsky JA, Berkower IJ. Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: advances in 1994-1995. AIDS 1995;9:S143-57.
13. Myers G, Josephs SF, Berzofsky JA, et al, eds. Human retroviruses and AIDS. Los Alamos: Theoretical Biology and Biophysics, 1989.
14. Margalit H, Spouge JL, Cornette JL, Cease KB, DeLisi C, Berzofsky JA. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol 1987;138:2213-29.
15. Colescott RL, Bossinger OD, Cook PI. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 1970;34:595-8.
16. Wahren B, Morfeldt-Mansson L, Beberfield G, et al. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol 198;61:2017-23.
17. Krowka J, Stites D, Mills J, et al. Effects of interleukin 2 and the envelope glycoprotein (gp120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus. Clin Exp Immunol 1988;72:179-85.
18. Krowka J, Stites D, Debs R, et al. Lymphocyte proliferate responses to soluble and liposome-conjugaled envelope peptides of HIV-1. J Immunol 1990;144:2535-40.
19. Mills KG, Kitchin PA, Mahon BP, et al. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1. J Immunol 1990;144:1677-83.
20. Mills KHG, Barnard AL, Williams M, et al. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. J Immunol 1991;147:3560-7